Match!
Nora Ibargoyen-Roteta
Basque Government
11Publications
5H-index
83Citations
Publications 12
Newest
Last.Brian Godman (Strathclyde Institute of Pharmacy and Biomedical Sciences)H-Index: 39
view all 4 authors...
Source
Last.Brian Godman (Strathclyde Institute of Pharmacy and Biomedical Sciences)H-Index: 39
view all 4 authors...
A jointly effort performed by HTAiIG on DEA, IG on ethics, EuroScannetwork and INAHTA is aiming to elaborate a toolkit that could aid organizations and individuals on the steps to be developed when considering disinvestment activities. This presentation refers to one of the chapters of that book on identification activities and disinvestment.
Source
Source
#1Iñaki Gutiérrez-Ibarluzea (Basque Government)H-Index: 14
#2Nora Ibargoyen-Roteta (Basque Government)H-Index: 5
view all 8 authors...
Background There is still a gap between what good quality CPGs recommend and real practice. For osteoarthritis, although best quality CPGs do not recommend SYSADOAS, a high degree of variability in prescription rates has been observed. Objectives To explore the reasons that explains SYSADOAS prescription for osteoarthritis. Methods A qualitative research was performed including one focus group to explore what General Practitioners (GPs) thought about this topic, and two in-depth interviews with ...
Source
#1Leonor Varela-LemaH-Index: 6
#2Alberto Ruano-Ravina (University of Santiago de Compostela)H-Index: 25
Last.Laura Sampietro-ColomH-Index: 14
view all 9 authors...
Objectives: When a new health technology has been approved by a health system, it is difficult to guarantee that it is going to be efficiently adopted, adequately used, and that effectiveness, safety, and consumption of resources and costs are in line with what was expected in preliminary investigations. Many governmental institutions promote the idea that efficient mechanisms should be established aimed at developing and incorporating continuous evidence into health technologies management. The...
6 CitationsSource
Introduction: A system for monitoring the use of aphaeresis in the treatment of ulcerative colitis (UC), named system for monitoring aphaeresis in ulcerative colitis (SiMAC), was designed in 2006 in the Basque Country. In the present study, the opinion of the clinicians who participated in SiMAC was evaluated, in order to identify the barriers and gather suggestions that could improve implementation of this kind of system. Methods: A mixed questionnaire was designed, in order to gather clinician...
Source
Last.Holger J. Schünemann (McMaster University)H-Index: 109
view all 7 authors...
Background In the last few years, a new non-pharmacological treatment, termed apheresis, has been developed to lessen the burden of ulcerative colitis (UC). Several methods can be used to establish treatment recommendations, but over the last decade an informal collaboration group of guideline developers, methodologists, and clinicians has developed a more sensible and transparent approach known as the Grading of Recommendations, Assessment, Development and Evaluation (GRADE). GRADE has mainly b...
16 CitationsSource
Last.José AsuaH-Index: 9
view all 3 authors...
Objectives To develop a guideline for health technology disinvestment.Methods The Nominal Group Technique was used to determine relevant aspects of disinvestment decision-making. Ideas reaching consensus and previous Spanish guidelines on the acquisition of new health technologies (GANT) and new genetic tests (GEN) structures were used to develop the domains and contents of GuNFT (Guideline for Not Funding Health Technologies). The draft was peer reviewed by local and international experts and t...
29 CitationsSource
Source
12